Investigating KCNQ1 Mistrafficking in Long QT Syndrome
调查长 QT 综合征中 KCNQ1 的错误贩卖
基本信息
- 批准号:10678328
- 负责人:
- 金额:$ 3.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:Action PotentialsBindingBiological AssayCardiacCardiac MyocytesCell LineCell membraneCell surfaceCellsCessation of lifeCharacteristicsClassificationColorCystic FibrosisDNADefectDiseaseDoseElectrocardiogramEndoplasmic ReticulumEvaluationExhibitsFlow CytometryFluorescence-Activated Cell SortingFunctional disorderGenesGenomeGoalsHeart ArrestHeart DiseasesImageImmunofluorescence ImmunologicImpairmentIndividualInduced MutationLeadLeftLibrariesLong QT SyndromeMammalian CellMediatingMembrane ProteinsMethodsMolecularMolecular BankMolecular ChaperonesMutationPharmaceutical PreparationsPharmacotherapyPhenotypePopulationPotassiumPotassium ChannelProteinsResearchRetinitis PigmentosaRhodopsinRiskRoleRomano-Ward SyndromeRouteSeveritiesSortingSpecificityStructureSurfaceSymptomsTestingVariantVoltage-Gated Potassium Channeldrug developmenthigh throughput screeningimprovedinsightloss of functionloss of function mutationmutantmutation screeningnext generation sequencingnovelpharmacologicresponsesmall moleculetraffickingtreatment choicevariant of unknown significancevoltage
项目摘要
Project Summary
Long QT syndrome (LQTS) is a cardiac disorder characterized by the prolongation of the latter
portion of the electrocardiogram trace (the QT interval) that increases risk of cardiac arrythmia, cardiac
arrest, and sudden unexpected death. Approximately 1 in 2500 individuals suffer from the congenital
form of LQTS, with 30-50% of cases being caused by mutations in the voltage gated potassium
channel protein KCNQ1 (type 1 LQTS, or LQT1). Over 250 LQT1-associated mutations in KCNQ1 have
been identified, but the impact of these mutations on the channel’s structure and function, and whether
there are common mechanisms through which these mutations lead to KCNQ1 dysfunction in LQT1, is
still unknown. The primary goal of this proposed project is to explore mistrafficking as a potential
mechanism of KCNQ1 loss of function in long QT syndrome.
Previous studies of LQT1-associated mutations in the KCNQ1 voltage sensing domain (VSD)
found that the majority decreased KCNQ1 trafficking to the plasma membrane and destabilized the
VSD. Additional studies have shown that mutations in KCNQ1 can lead to retention in the endoplasmic
reticulum (ER) and increased proteasomal degradation. This has led to the hypothesis that
mistrafficking is a common mechanism of protein dysfunction in LQT1. Mistrafficking has been
identified as a disease mechanism in several other membrane-protein associated diseases, such as
cystic fibrosis and retinitis pigmentosa, and in the case of cystic fibrosis, drugs have been developed to
rescue mistrafficking and alleviate disease symptoms. This leads to the additional hypothesis that drugs
that bind nascent KCNQ1 channels and increase their stability can increase the trafficking of KCNQ1.
In line with these hypotheses, I propose two aims: 1) to classify mutations across KCNQ1 based
on their impact on KCNQ1 trafficking, and 2) to develop a high throughput screening method to identify
small molecules that increase cell surface trafficking. In Aim 1, I will classify the trafficking of all
possible KCNQ1 variants with a fluorescence-activated cell sorting (FACS)-based deep mutational
scanning method. This will allow me to determine whether the majority of LQT1-associated mutations
cause mistrafficking and also provide information on variants of unknown significance (VUS) and other
KCNQ1 variants. In Aim 2, I will utilize immunofluorescence and high content imaging to screen for
small molecules that increase WT or mutant KCNQ1 trafficking. This will test the hypothesis that
KCNQ1 mistrafficking is rescuable with small molecules. Together, the results of these aims will provide
further insight into the molecular mechanisms behind KCNQ1 dysfunction in LQT1 and explore a
possible route for developing novel treatments for LQT1.
项目摘要
长QT综合征(LQTS)是一种以QT间期延长为特征的心脏疾病
增加心律失常风险的心电图描记(QT间期)的一部分,心脏
突然死亡,突然意外死亡。大约每2500人中就有1人患有先天性
LQTS的形式,其中30-50%的病例是由电压门控钾突变引起的
通道蛋白KCNQ 1(1型LQTS或LQT 1)。KCNQ 1中超过250个LQT 1相关突变,
但是这些突变对通道结构和功能的影响,以及是否
这些突变导致LQT 1中KCNQ 1功能障碍的共同机制,
仍然未知。这个项目的主要目标是探索误传作为一种潜在的
长QT综合征中KCNQ 1功能丧失的机制
KCNQ 1电压敏感域(VSD)中LQT 1相关突变的既往研究
发现大多数减少KCNQ 1运输到质膜和不稳定的
室间隔缺损其他研究表明,KCNQ 1突变可导致KCNQ 1滞留在内质网中,
内质网(ER)和蛋白酶体降解增加。这导致了一种假设,
错配是LQT 1蛋白功能障碍的常见机制。误传一直是
被鉴定为其他几种膜蛋白相关疾病的疾病机制,例如
囊性纤维化和色素性视网膜炎,在囊性纤维化的情况下,已经开发了药物,
抢救误服,缓解疾病症状。这导致了另一个假设,即药物
结合新生的KCNQ 1通道并增加其稳定性可以增加KCNQ 1的运输。
根据这些假设,我提出了两个目标:1)基于KCNQ 1对突变进行分类
研究它们对KCNQ 1贩运的影响,2)开发一种高通量筛选方法,
增加细胞表面运输的小分子。在目标1中,我将把所有贩运人口
可能的KCNQ 1变体具有基于荧光激活细胞分选(FACS)的深度突变
扫描法这将使我能够确定大多数LQT 1相关突变是否
导致误检,并提供关于未知意义的变体(VUS)和其他
KCNQ 1变体。在目标2中,我将利用免疫荧光和高内涵成像来筛选
增加WT或突变型KCNQ 1运输的小分子。这将检验假设,
KCNQ 1的错误反应可以用小分子来挽救。总之,这些目标的结果将提供
进一步深入了解LQT 1中KCNQ 1功能障碍背后的分子机制,并探索
开发LQT 1新疗法的可能途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Katherine R Moster其他文献
Katherine R Moster的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321481 - 财政年份:2024
- 资助金额:
$ 3.3万 - 项目类别:
Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321480 - 财政年份:2024
- 资助金额:
$ 3.3万 - 项目类别:
Continuing Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
- 批准号:
2317664 - 财政年份:2024
- 资助金额:
$ 3.3万 - 项目类别:
Standard Grant
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
- 批准号:
EP/X039420/1 - 财政年份:2024
- 资助金额:
$ 3.3万 - 项目类别:
Research Grant
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 3.3万 - 项目类别:
Fellowship
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
- 批准号:
DP240103289 - 财政年份:2024
- 资助金额:
$ 3.3万 - 项目类别:
Discovery Projects
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
- 批准号:
2419915 - 财政年份:2024
- 资助金额:
$ 3.3万 - 项目类别:
Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 3.3万 - 项目类别:
Research Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
- 批准号:
2347997 - 财政年份:2024
- 资助金额:
$ 3.3万 - 项目类别:
Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 3.3万 - 项目类别:
Discovery Projects